Vilon: Lys-Glu and reparative-process claims — RU2139085C1
В.Х. Хавинсон, В.Г. Морозов, В.В. Малинин, С.В. Серый · 1999 · RU2139085C1 · patent family 20207251
Published 1999-10-10.
Reported patent results
Narrative findings; numerical extraction incomplete
The patent reports improvement during combined care, but the clinical series lack a clear concurrent untreated comparison.
Vilon patent clinical descriptions include 45 salivary-gland patients, 15 slow-healing wound cases, 19 maxillofacial infections and 9 postoperative cancer cases.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Salivary-stone postoperative course | Edema/infiltration reportedly resolved 3–4 days after surgery, with cessation of purulent discharge | Stone removal and other care prevent attribution to Vilon |
| Inflammatory salivary-gland cases | Pain/discharge reportedly stopped around days 4–5, with more salivation and reduced edema | Clinical narrative; no numerical controlled effect estimate |
| Other wound series | Reduced pain/edema and faster cleansing or scar formation reported | Exact comparative healing times not transcribed; cohorts must remain separate |
These are selected adjunctive reports, not validated response rates. Separate wound, gland and cancer populations cannot be pooled into one efficacy denominator.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Molecule. The document identifies the Lys-Glu dipeptide and proposed reparative applications.
The patent is a molecular and use source, not independent confirmation of clinical immune or longevity benefit.
- Publication
- RU2139085C1 ↗ · 1999-10-10
- Earliest priority / filing
- 1998-06-23 / 1998-06-23
- Original applicant / assignee
- Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии"
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 20207251 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Agent stimulating reparative processes and method of its use
Inventors: В.Х. Хавинсон; В.Г. Морозов; В.В. Малинин; С.В. Серый.
RU2139085C1 · US6642201B1 · EP1089753B1 · JP4489946B2 · ATE245434T1 · AU776693B2 · CA2335362C · CH692477A5 · DE69909794T2 · IL140412A0 · WO1999066948A2
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- The patent is a molecular and use source, not independent confirmation of clinical immune or longevity benefit.
- These are selected adjunctive reports, not validated response rates. Separate wound, gland and cancer populations cannot be pooled into one efficacy denominator.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-20207251. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: В.Х. Хавинсон, В.Г. Морозов, В.В. Малинин, С.В. Серый. Vilon: Lys-Glu and reparative-process claims — RU2139085C1 RU2139085C1 · patent family 20207251 1999.
Molekul research summary: https://molekul.io/research/patent-ru2139085c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry